GO
Loading...

Pfizer's Pipeline Plan

Monday, 30 Apr 2012 | 12:45 PM ET

Catherine Arnold, senior analyst at Credit Suisse, discusses her company's "buy" rating on Pfizer ahead of the company's Q1 earnings report.